|
Presented by
Hosted by
|
Transforming Medicine through Innovation “From Idea to Market”
Online Registration is now closed. We will, however, allow on-site registration during our posted registration hours, however there will be a $25 processing fee. Thank you to all that registered, and we look forward to an informative conference! Per the Cancellation Policy stated on the Registration page, all registrations are now non-refundable since the June 1 deadline. Thank you - Conference Planning Committee
Highlights
Who Should Attend?
For conference agenda specifics contact Lisa Tedesco: For registration and hotel information, contact Veronica Doga: For more information on NIH SBIR/STTR Program: Agenda (Subject to Change) For the printer-friendly version of the detailed agenda click HERE The following is a summary of session topics and times only:
Narrative Descriptions of Sessions Day 1 Day One Agenda The biotechnology community has not been spared the wrath of the US economic downturn. However, the situation is not entirely bleak. Small businesses continue to innovate, make scientific advances, and forge new partnerships that leverage and expedite their commercialization efforts. Latest reports indicate that entrepreneurship rose in this recession and may be the remedy to the shrinking corporate pipelines. Some forecast dire straits for entrepreneurs. So what is the current investor and partnering climate like for life science companies? What are the future trends? Which bioscience sectors have been most successful in attracting investments and partnerships? Where does the NIH SBIR-STTR program fit in? Come hear James Greenwood, CEO and President of BIO discuss the latest advances in biomedical research and share his insights into where the industry is headed in today’s uncertain global economic climate. Day One Agenda Day One Agenda Day One Agenda
Day One Agenda Day One Agenda The last several years have witnessed an increasing number of university faculty who are spinning out companies using intellectual property (IP) derived from their academic research. While many institutions are supporting efforts to boost start-up activity, there remain a number of challenges associated with the successful transition from academic culture to the business world. This session will discuss the process of “Ivory Tower Innovation” with a focus on negotiating a successful IP agreement for your small business. Topics will also include avoiding common pitfalls, such as conflict of interest concerns, and deciding what role you should play in this new venture. Panelists will provide various perspectives on this process from the point-of-view of the inventor, the technology transfer specialist, and the person leading operations at the small business. Day One Agenda Many biomedical research projects and their resulting products need scientific and technical talent and commercialization partners from a broad spectrum of diverse areas. A few of the tools which are available to assist with identifying industry, university, and commercial partners and with negotiating agreements with them will be presented. These tools include the NIH “Pipeline to Partnerships,” “Turbo Negotiator” (a product of the University-Industry Demonstration Partnership of the National Academies), and the National Institutes of Standards and Technology’s Manufacturing Extension Partnership’s “Innovation Marketplace.” Demonstrations of these tools will also be available during the conference. Day One Agenda Day One Agenda Network with other attendees in a structured and “fun” environment. Be sure to have plenty of business cards handy for this session.
Day 2 Business Planning Basics Are you a researcher who is having difficulty with entrepreneurial thinking? Are you struggling with how to start, finance, and build your business? Do you want to be a lifestyle company, a foundation, or perhaps grow to an initial public offering? This session will help you learn why you should write a business plan and give you some thought provoking ideas and tips for creating a plan that will help you avoid critical business mistakes. Attend this session to begin to design your “business roadmap to success.” Specific topics to be covered include: (1) The Business Plan Overview, (2) Developing and Organizing Content to include the Executive Summary, Company Profit, Market Research and Analysis, Marketing Plan, Operations, Human Resources and Finances, and (3) Overview of funding options to include: SBIR, Angels, Venture Capitalist, Launching Investors Strategies for Commercialization Determining your strategy to bring your innovation into the marketplace depends on (1) assessing the current commercialization environment of your specific industry sector and (2) your personal vision for the technology based on your personal business philosophy. Various options are then available such as seeking a strategic alliance to develop, market or distribute your product, licensing your technology to others, pouring in more “sweat equity”, or perhaps obtaining venture capital, angel, or corporate investments. This session will help you determine if bootstrapping, spinning off the technology, or perhaps taking on an investment or strategic partner is best for you. Life Science Ventures and Angels In today’s life sciences environment, as small businesses look for much needed capital financing for their sometimes risky ventures, venture capital presents an opportunity for small businesses to access early and late stage investment from venture funds that focus on life science and biomedical innovations. Panelists will discuss venture capital and angel investor criteria and hurdles required for investment in early stage biotech opportunities. They will also discuss how to prepare for raising risk capital, differences in stages of investment and the due diligence process. Building Corporate Alliances & Partnerships Building alliances to help commercialize biotechnology and health-related products can be more difficult than obtaining the funding to do the research, especially in these economic hard times. It’s almost impossible to go it alone. This session will equip small businesses with the knowledge on building their phase III strategies for bringing their technologies to the marketplace through building alliances and partnerships with corporate partners – whether it be how to start the relationship-building process, issues that need to be considered when transferring technologies through testing, licensing, partnering, consulting, and overall business development strategies for effective partnering. Benefits of Incubator Programs Business incubation is a business support process that accelerates the successful development of start-up and fledgling companies by providing entrepreneurs with an array of targeted resources and services. Business incubators nurture the development of entrepreneurial companies, helping them survive and grow during the start-up period, when they are most vulnerable. The most common goals of incubation programs are creating jobs in a community, enhancing a community’s entrepreneurial climate, retaining businesses in a community, building or accelerating growth in a local industry, and diversifying local economies while producing successful firms that will leave the program financially viable and freestanding. This session will discuss best practices in business incubation and the critical factors for success for biotech based companies. A Peek Into the NIH, CDC, and FDA: Special Programs and Resources The “Peek Into the NIH, CDC, and FDA” sessions will highlight the scientific priority areas for SBIR/STTR for twelve NIH institutes and centers (ICs), as well as the CDC and the FDA and then expand upon opportunities and research resources available to small businesses beyond the SBIR/STTR program. Topics of discussion will include programs that encourage collaborating with SBIR/STTR communities, non-SBIR/STTR funding opportunities/mechanisms, NIH, CDC, and FDA resources available to the extramural research community, and NIH collaboration mechanisms. NIH Technical Assistance Programs You thought being selected for an award was difficult, well getting to the marketplace is even more challenging. Biomedical research can take millions of dollars and 10+ years before a product reaches consumer hands. So how are you planning to get over this huge hurdle? NIH offers several assistance programs to help SBIR awardees strategize how to commercialize their SBIR-developed products. Join this session to find out what opportunities might be available for you and how to become involved. Leveraging Your State Resources Unbeknown to many, a wealth of SBIR/STTR information and support is often available right in your own backyard. Many state organizations are available and interested in assisting you with applying for an SBIR or STTR grants/contract, and some actually have funding available to help defer the costs of preparing an application. Join this group to learn specifically about the various resources available in Nebraska and other states, and where to look for opportunities in your state. Navigating the FDA Interactive Multi-Media Panel: Commercialization of Behavioral Services, Interventions and Products Moving from R&D to Manufacturing Manufacturing is a later stage of commercialization, but typically something companies begin to think about in Phase 1 and formulate during Phase 2 under SBIR & STTR. Choice of a manufacturing strategy can have a long-term impact on finances, corporate strategy and the lifestyle of the corporate leaders. This session will discuss the core scale-up and production strategies life science companies employ that can reduce costs and time to market while meeting quality and regulatory requirements as well as a corporate strategy. Examples will be drawn from NIH SBIR awardees. Commercializing Your Healthcare/IT/Media Product Each year thousands of healthcare-related products are created but only some of them become commercial successes; almost all of the ones that make it to the market, get sold, and are ultimately deployed have some common characteristics. Shahid will describe some of those characteristics and help you find ways of getting the attention of your customers, explaining your product to them in a concise and meaningful way, devising pricing and partnering strategies, and finally figuring out how to get paid for what you’ve created. It’s difficult to have your product’s messaging make it through the noise in an ordinary market – but, of course we’re not living in ordinary times so things are even harder. Shahid will help you devise the right strategies so that you can rise above the herd and get noticed in the marketplace. Reimbursement When planning to bring your product or service to market, have you included effective reimbursement strategies? Are you familiar with the Federal regulations and policies that will affect the probability of reimbursement? Do you know the correct CMS code for your product? Do you know the difference between FDA and CMS review? Are you aware that FDA approval alone does not entitle a device to reimbursement coverage? If you answered “no” to any of these questions, you should attend this session!
Abstracts Due: May 31, 2009 Twenty Five university researchers will be selected to present their non-proprietary scientific findings at the poster session. The goals of the session are to:
This is not an exhibit or tradeshow, but is instead an opportunity to share information. Submission Deadline: May 31, 2009
Registration
Online Registration is now closed. We will, however, allow on-site registration during our posted registration hours, however there will be a $25 processing fee. Thank you to all that registered, and we look forward to an informative conference! Per the Cancellation Policy stated on the Registration page, all registrations are now non-refundable since the June 1 deadline. Thank you - Conference Planning Committee The 11th Annual NIH SBIR/STTR Conference will be held on June 30 - July 1, 2009 at the Qwest Center Omaha, located minutes from Eppley Airfield, in downtown Omaha and attached via skyway to the Hilton Hotel, the official hotel for this year's conference. The Qwest Center Omaha is located at:
Qwest Center Omaha Standard Registration: To register for the Conference by payment with credit card, click HERE To register for the Conference by payment with check, click HERE
Early bird registration will end on April 15 and regular registration will be from April 16 – June 25. If you have not registered online by the June 25th cutoff, you may register onsite for an additional $25 fee. All payments must be received before the conference start. If you choose to register "Pay by credit card" and have not paid by credit card online, you MUST render full payment on the day of the conference before attendance is allowed. If you choose to register "Pay by check" and the checks are not received by the COB June 25, 2009 deadline, you MUST render full payment on the day of the conference before attendance will be allowed. To cancel your registration, you must contact the conference coordinator by close of business on May 31, 2009. All payments and registrations paid will be final and non-reimbursable as of June 1, 2009. If you cancel your registration before the June 1 deadline, you will be returned your registration fee minus a $25 processing fee. Lodging
The Hilton Omaha hotel, Nebraska's only four diamond property, is connected to the brand new Qwest Center Omaha, just blocks from the historic Old Market and is this year's NIH SBIR/STTR National Conference Hotel. The Hilton Omaha hotel is located adjacent to the Old Market and is minutes from Henry Doorly Zoo, Omaha Children's Museum, the Durham Western Heritage Museum, Joslyn Art Museum. The Hilton Omaha is also only three miles from Eppley Airfield and offers complimentary 24-hour shuttle to and from the airport. All Hilton Omaha's guestrooms feature both wired and wireless high-speed Internet access. Enjoy meals in the custom designed Liberty Tavern Restaurant and Lounge or enjoy a freshly brewed Latte or other gourmet coffee on our outdoor furnished patio while leafing through your complimentary morning USA Today®. For a reasonable fee enjoy our full service health club and spa or relax by our complimentary indoor pool. Enjoy Nebraska hospitality at its finest - Travel Should Take You Places!™ A block of rooms have been reserved for June 26, 2009 - July 3, 2009. The special room rate of $125/nt. will be available until June 5th or until the group block is sold-out, whichever comes first. Booking a reservation from the Hilton's site is simple. To begin the process, click on the link below to take you directly to the conference hotel reservation site to receive your group's preferred rate. If you need additional nights stay, the group rate will be available from June 26 - July 3, or until the rooms are sold-out. See you at the Hilton Omaha! We hope you enjoy your stay in Omaha! Group Name: 11th Annual NIH National SBIR/STTR Conference
Submission Deadline: May 31, 2009 Poster Submission Instructions
Submission Deadline: May 31, 2009 For More Information Contact: Narrative Descriptions of Sessions Day 1 Current State of the Biotechnology Industry The biotechnology community has not been spared the wrath of the US economic downturn. However, the situation is not entirely bleak. Small businesses continue to innovate, make scientific advances, and forge new partnerships that leverage and expedite their commercialization efforts. Latest reports indicate that entrepreneurship rose in this recession and may be the remedy to the shrinking corporate pipelines. Some forecast dire straits for entrepreneurs. So what is the current investor and partnering climate like for life science companies? What are the future trends? Which bioscience sectors have been most successful in attracting investments and partnerships? Where does the NIH SBIR-STTR program fit in? Come hear James Greenwood, CEO and President of BIO discuss the latest advances in biomedical research and share his insights into where the industry is headed in today’s uncertain global economic climate. Nuts and Bolts of the NIH SBIR and STTR Programs An In-Depth Look at the NIH SBIR/STTR Receipt, Referral, and Review Processes Preparing a Successful Application – Tales From those Who “Have Been There…Done That” Indirect Cost Rates and Accounting Systems Workshop Compliance & Just-in-Time Ivory Tower Innovation & University Start-Ups The last several years have witnessed an increasing number of university faculty who are spinning out companies using intellectual property (IP) derived from their academic research. While many institutions are supporting efforts to boost start-up activity, there remain a number of challenges associated with the successful transition from academic culture to the business world. This session will discuss the process of “Ivory Tower Innovation” with a focus on negotiating a successful IP agreement for your small business. Topics will also include avoiding common pitfalls, such as conflict of interest concerns, and deciding what role you should play in this new venture. Panelists will provide various perspectives on this process from the point-of-view of the inventor, the technology transfer specialist, and the person leading operations at the small business. Tools for Building and Facilitating Partnerships Many biomedical research projects and their resulting products need scientific and technical talent and commercialization partners from a broad spectrum of diverse areas. A few of the tools which are available to assist with identifying industry, university, and commercial partners and with negotiating agreements with them will be presented. These tools include the NIH “Pipeline to Partnerships,” “Turbo Negotiator” (a product of the University-Industry Demonstration Partnership of the National Academies), and the National Institutes of Standards and Technology’s Manufacturing Extension Partnership’s “Innovation Marketplace.” Demonstrations of these tools will also be available during the conference. Protecting Your SBIR/STTR Intellectual Property Rights Through iEdison Invention Reporting Speed Dating Network with other attendees in a structured and “fun” environment. Be sure to have plenty of business cards handy for this session.
Day 2 Business Planning Basics Are you a researcher who is having difficulty with entrepreneurial thinking? Are you struggling with how to start, finance, and build your business? Do you want to be a lifestyle company, a foundation, or perhaps grow to an initial public offering? This session will help you learn why you should write a business plan and give you some thought provoking ideas and tips for creating a plan that will help you avoid critical business mistakes. Attend this session to begin to design your “business roadmap to success.” Specific topics to be covered include: (1) The Business Plan Overview, (2) Developing and Organizing Content to include the Executive Summary, Company Profit, Market Research and Analysis, Marketing Plan, Operations, Human Resources and Finances, and (3) Overview of funding options to include: SBIR, Angels, Venture Capitalist, Launching Investors Strategies for Commercialization Determining your strategy to bring your innovation into the marketplace depends on (1) assessing the current commercialization environment of your specific industry sector and (2) your personal vision for the technology based on your personal business philosophy. Various options are then available such as seeking a strategic alliance to develop, market or distribute your product, licensing your technology to others, pouring in more “sweat equity”, or perhaps obtaining venture capital, angel, or corporate investments. This session will help you determine if bootstrapping, spinning off the technology, or perhaps taking on an investment or strategic partner is best for you. Life Science Ventures and Angels In today’s life sciences environment, as small businesses look for much needed capital financing for their sometimes risky ventures, venture capital presents an opportunity for small businesses to access early and late stage investment from venture funds that focus on life science and biomedical innovations. Panelists will discuss venture capital and angel investor criteria and hurdles required for investment in early stage biotech opportunities. They will also discuss how to prepare for raising risk capital, differences in stages of investment and the due diligence process. Building Corporate Alliances & Partnerships Building alliances to help commercialize biotechnology and health-related products can be more difficult than obtaining the funding to do the research, especially in these economic hard times. It’s almost impossible to go it alone. This session will equip small businesses with the knowledge on building their phase III strategies for bringing their technologies to the marketplace through building alliances and partnerships with corporate partners – whether it be how to start the relationship-building process, issues that need to be considered when transferring technologies through testing, licensing, partnering, consulting, and overall business development strategies for effective partnering. Benefits of Incubator Programs Business incubation is a business support process that accelerates the successful development of start-up and fledgling companies by providing entrepreneurs with an array of targeted resources and services. Business incubators nurture the development of entrepreneurial companies, helping them survive and grow during the start-up period, when they are most vulnerable. The most common goals of incubation programs are creating jobs in a community, enhancing a community’s entrepreneurial climate, retaining businesses in a community, building or accelerating growth in a local industry, and diversifying local economies while producing successful firms that will leave the program financially viable and freestanding. This session will discuss best practices in business incubation and the critical factors for success for biotech based companies. A Peek Into the NIH, CDC, and FDA: Special Programs and Resources The “Peek Into the NIH, CDC, and FDA” sessions will highlight the scientific priority areas for SBIR/STTR for twelve NIH institutes and centers (ICs), as well as the CDC and the FDA and then expand upon opportunities and research resources available to small businesses beyond the SBIR/STTR program. Topics of discussion will include programs that encourage collaborating with SBIR/STTR communities, non-SBIR/STTR funding opportunities/mechanisms, NIH, CDC, and FDA resources available to the extramural research community, and NIH collaboration mechanisms. NIH Technical Assistance Programs You thought being selected for an award was difficult, well getting to the marketplace is even more challenging. Biomedical research can take millions of dollars and 10+ years before a product reaches consumer hands. So how are you planning to get over this huge hurdle? NIH offers several assistance programs to help SBIR awardees strategize how to commercialize their SBIR-developed products. Join this session to find out what opportunities might be available for you and how to become involved. Leveraging Your State Resources Unbeknown to many, a wealth of SBIR/STTR information and support is often available right in your own backyard. Many state organizations are available and interested in assisting you with applying for an SBIR or STTR grants/contract, and some actually have funding available to help defer the costs of preparing an application. Join this group to learn specifically about the various resources available in Nebraska and other states, and where to look for opportunities in your state. Navigating the FDA Interactive Multi-Media Panel: Commercialization of Behavioral Services, Interventions and Products Moving from R&D to Manufacturing Manufacturing is a later stage of commercialization, but typically something companies begin to think about in Phase 1 and formulate during Phase 2 under SBIR & STTR. Choice of a manufacturing strategy can have a long-term impact on finances, corporate strategy and the lifestyle of the corporate leaders. This session will discuss the core scale-up and production strategies life science companies employ that can reduce costs and time to market while meeting quality and regulatory requirements as well as a corporate strategy. Examples will be drawn from NIH SBIR awardees. Commercializing Your Healthcare/IT/Media Product Each year thousands of healthcare-related products are created but only some of them become commercial successes; almost all of the ones that make it to the market, get sold, and are ultimately deployed have some common characteristics. Shahid will describe some of those characteristics and help you find ways of getting the attention of your customers, explaining your product to them in a concise and meaningful way, devising pricing and partnering strategies, and finally figuring out how to get paid for what you’ve created. It’s difficult to have your product’s messaging make it through the noise in an ordinary market – but, of course we’re not living in ordinary times so things are even harder. Shahid will help you devise the right strategies so that you can rise above the herd and get noticed in the marketplace. Reimbursement When planning to bring your product or service to market, have you included effective reimbursement strategies? Are you familiar with the Federal regulations and policies that will affect the probability of reimbursement? Do you know the correct CMS code for your product? Do you know the difference between FDA and CMS review? Are you aware that FDA approval alone does not entitle a device to reimbursement coverage? If you answered “no” to any of these questions, you should attend this session!
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright, 2009. NBDC vdoga[at sign]mail.unomaha.edu | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
